KGK Science Inc.   Report issue

For profit Phase 1 Phase 2
Founded: London CRO United States (1997)

Organization Overview

First Clinical Trial
2008
NCT01873820
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

KGK Science | KGK Science Inc. | KGK Synergize | KGK Synergize Inc. | Marealis AS | Qualified Investigator

Active Ingredients

Drugs in Phase 2 Trials (38)

activamp (1 trial)

amino acids (Freamine) (1 trial)

bacillus subtilis (1 trial)

betaine (1 trial)

bifidobacterium longum (1 trial)

cellulose (1 trial)

chickpea (1 trial)

chondroitin (1 trial)

cranberry (1 trial)

cyanocobalamin (berocca) (1 trial)

dextrose (1 trial)

eurycoma longifolia (1 trial)

eurycomalongifoliawater extract (1 trial)

flower pollen (1 trial)

gfa-918 (1 trial)

ginseng (2 trials)

glucosamine (1 trial)

hawthorn berry extract (2 trials)

hypromelloses (1 trial)

kiwi fruit (1 trial)

labisia pumila (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus helveticus (1 trial)

lactobacillus rhamnosus (1 trial)

leucine (1 trial)

levocarnitine (carnitor) (2 trials)

marealis refined peptide (2 trials)

multivitamins (1 trial)

nattokinase (1 trial)

nicotinamide (2 trials)

potato powder (1 trial)

psilocybin (2 trials)

serratiopeptidase (1 trial)

theanine (3 trials)

vitamin c (5 trials)

xylooligosaccharide (1 trial)

yinhsing (1 trial)

Drugs in Phase 1 Trials (20)

bacillus coagulans (1 trial)

cannabidiol (Epidiolex) (1 trial)

cannabis (1 trial)

chamomile (1 trial)

colchicine (colbenemid) (1 trial)

curcumin (1 trial)

diphenhydramine (benadryl) (1 trial)

fish hydrolysate (1 trial)

lemon oil (1 trial)

melatonin (2 trials)

niacin (1 trial)

passion flower (1 trial)

rebaudioside (1 trial)

resveratrol (1 trial)

spanish black radish (1 trial)

sucrose (1 trial)

tetrahydrocannabinol (1 trial)

ubiquinone (1 trial)

valeriana officinalis (1 trial)

vitis vinifera (1 trial)

Drugs in Other Trials (19)

acetaminophen (tylenol) (1 trial)

almond (1 trial)

amaz-02 (1 trial)

angelica (1 trial)

Benfotiamine (1 trial)

beta-glucans (1 trial)

bifidobacterium breve (1 trial)

caffeine (1 trial)

cobalamin (1 trial)

collagen (1 trial)

lactobacillus plantarum (1 trial)

l-epigallocatechin (1 trial)

pine bark extract (1 trial)

pyridoxine (1 trial)

silver hydrosol (1 trial)

tetrahydropalmatine (1 trial)

vitamin d3 (1 trial)

whole cell euglena (1 trial)

willow bark (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 2)

Constipation (Phase 2)

Diarrhea (Phase 2)

Hyperlipidemias (Phase 2)

Hyperlipoproteinemias (Phase 2)

Hypertension (Phase 2)

Irritable Bowel Syndrome (Phase 2)

Marijuana Abuse (Phase 1)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overweight (Phase 2)

Prehypertension (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 56
  • # of Trial APIs: 77